Calcitriol and Skin hyperpigmentation - a phase IV clinical study of FDA data

Summary:

Skin hyperpigmentation is reported as a side effect among people who take Calcitriol (calcitriol), especially for people who are female, 50-59 old, also take Magnevist, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Skin hyperpigmentation when taking Calcitriol. It is created by eHealthMe based on reports of 23,957 people who have side effects when taking Calcitriol from the FDA, and is updated regularly.

What is Calcitriol?

Calcitriol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 24,162 Calcitriol users. Check the latest studies of Calcitriol.

What is Skin hyperpigmentation?

Skin hyperpigmentation (disorders affect the colour of your skin) is found to be associated with 641 drugs and 812 conditions by eHealthMe. Check the latest studies of Skin hyperpigmentation.

On Aug, 08, 2026

23,957 people reported to have side effects when taking Calcitriol.
Among them, 46 people (0.19%) have Skin hyperpigmentation.

Could Calcitriol cause Skin hyperpigmentation?

Among these 46 people:

What is the gender of people who have Skin hyperpigmentation when taking Calcitriol? *

female: 78.26 %
male: 21.74 %

What is the age of people who have Skin hyperpigmentation when taking Calcitriol? *

What are other drugs people take besides Calcitriol? *

What are other side effects people have besides Skin hyperpigmentation? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 41 people, 89.13%
Skin Induration (an abnormally hard spot or area on the skin): 37 people, 80.43%
Skin Hypertrophy (skin cells enlarges): 33 people, 71.74%
Pain: 30 people, 65.22%
Skin Tightness: 28 people, 60.87%
Weakness: 28 people, 60.87%
Joint Range Of Motion Decreased (disease of joint movement): 26 people, 56.52%
Mobility Decreased (ability to move is reduced): 24 people, 52.17%
Pain In Extremity: 23 people, 50.00%
Oedema Peripheral (superficial swelling): 23 people, 50.00%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 14 people, 30.43%
Anaemia (lack of blood): 9 people, 19.57%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 15.22%
Restless Leg Syndrome (a powerful urge to move your legs): 7 people, 15.22%
Hypotension (abnormally low blood pressure): 7 people, 15.22%
Pain: 6 people, 13.04%
Stress And Anxiety: 3 people, 6.52%
Bipolar Disorder (mood disorder): 3 people, 6.52%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 6.52%
High Blood Pressure: 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Calcitriol and have Skin hyperpigmentation?

- Check whether Skin hyperpigmentation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Calcitriol:

Calcitriol (24,162 reports)

Browse all side effects of Calcitriol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hyperpigmentation:

Skin hyperpigmentation (641 drugs)

Browse all the conditions that are associated with Skin hyperpigmentation:

Skin hyperpigmentation (812 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol (the active ingredients of Calcitriol) and Calcitriol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.